← USPTO Patent Grants

Treatments administering chimeric IgG Fc receptor comprising an extracellular domain of CD64

Grant US12590138B2 Kind: B2 Mar 31, 2026

Assignee

Regents of the University of Minnesota

Inventors

Jianming Wu, Bruce Kenneth Walcheck, Robert Harrison Hullsiek, Yungfang Li, Hemant Kumar Mishra

Abstract

A recombinant immune cell expresses a heterologous IgG Fc receptor. In some embodiments, the heterologous IgG Fc receptor can be a chimeric IgG Fc receptor. Generally, the chimeric IgG Fc receptor includes an extracellular domain, a transmembrane domain, and an intracellular domain. The extracellular domain generally includes a sufficient portion of CD64 to bind to an IgG Fc region. The intracellular domain of the chimeric IgG Fc receptor includes a sufficient portion of an Fc receptor allowing immunoreceptor tyrosine-based activation motif (ITAM) to initiate cell signaling when an IgG Fc region binds to the extracellular domain.

CPC Classifications

A61K 38/177 A61K 38/1774 A61K 40/11 A61K 40/15 A61K 40/31 A61K 40/33 A61K 40/42 A61K 40/4224 A61K 2239/15 A61K 2239/21 A61K 2239/22 C07K 14/70503 C07K 14/70535 C07K 19/00 C07K 2319/00 C07K 2319/50 C07K 2319/02 C07K 2319/03 C07K 2319/74 C07K 16/30 C12N 5/0637 C12N 5/0646

Filing Date

2023-09-26

Application No.

18474781

Claims

9